Arimoclomol Completed Phase 2 / 3 Trials for Amyotrophic Lateral Sclerosis (ALS) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2 / 3
clinicaltrials.gov IdentifierTitleDrugs
NCT00244244A Multicenter, Dose Ranging Safety and Pharmacokinetics Study of Arimoclomol in ALS